A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States.

Standard

A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States. / Jeldres, Claudio; Baillargeon-Gagne, Sara; Liberman, Daniel; Isbarn, Hendrik; Capitanio, Umberto; Shariat, Shahrokh F; Sun, Maxine; Lughezzani, Giovanni; Perrotte, Paul; Montorsi, Francesco; Graefen, Markus; Karakiewicz, Pierre I.

in: UROLOGY, 2009.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Jeldres, C, Baillargeon-Gagne, S, Liberman, D, Isbarn, H, Capitanio, U, Shariat, SF, Sun, M, Lughezzani, G, Perrotte, P, Montorsi, F, Graefen, M & Karakiewicz, PI 2009, 'A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States.', UROLOGY. <http://www.ncbi.nlm.nih.gov/pubmed/19616828?dopt=Citation>

APA

Jeldres, C., Baillargeon-Gagne, S., Liberman, D., Isbarn, H., Capitanio, U., Shariat, S. F., Sun, M., Lughezzani, G., Perrotte, P., Montorsi, F., Graefen, M., & Karakiewicz, P. I. (2009). A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States. UROLOGY. http://www.ncbi.nlm.nih.gov/pubmed/19616828?dopt=Citation

Vancouver

Jeldres C, Baillargeon-Gagne S, Liberman D, Isbarn H, Capitanio U, Shariat SF et al. A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States. UROLOGY. 2009.

Bibtex

@article{e8b52c41c84c44d8aae6f8ef525bc594,
title = "A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States.",
abstract = "OBJECTIVE: To examine temporal, geographic, socioeconomic, and clinical determinants of cytoreductive nephrectomy (CNT) use in the surveillance, epidemiology, and end results (SEER) database, because CNT is known to improve survival in patients with metastatic renal cell carcinoma (mRCC). METHODS: Within the SEER database, we identified 6226 mRCC patients, who were either treated with CNT (n = 2038) or underwent no surgery (n = 4188) between 1989 and 2004. Chi-square and chi(2) trend tests, as well as multivariate logistic regression models, were used to assess the effect of age, gender, race, region of residence, and year of surgery on the rate of CNT. Adjustment was made for the size of the primary tumor. RESULTS: The overall rate of CNT was 30.5%. The rate of CNT increased in the most recent year quartile (P",
author = "Claudio Jeldres and Sara Baillargeon-Gagne and Daniel Liberman and Hendrik Isbarn and Umberto Capitanio and Shariat, {Shahrokh F} and Maxine Sun and Giovanni Lughezzani and Paul Perrotte and Francesco Montorsi and Markus Graefen and Karakiewicz, {Pierre I}",
year = "2009",
language = "Deutsch",
journal = "UROLOGY",
issn = "0090-4295",
publisher = "Elsevier Inc.",

}

RIS

TY - JOUR

T1 - A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States.

AU - Jeldres, Claudio

AU - Baillargeon-Gagne, Sara

AU - Liberman, Daniel

AU - Isbarn, Hendrik

AU - Capitanio, Umberto

AU - Shariat, Shahrokh F

AU - Sun, Maxine

AU - Lughezzani, Giovanni

AU - Perrotte, Paul

AU - Montorsi, Francesco

AU - Graefen, Markus

AU - Karakiewicz, Pierre I

PY - 2009

Y1 - 2009

N2 - OBJECTIVE: To examine temporal, geographic, socioeconomic, and clinical determinants of cytoreductive nephrectomy (CNT) use in the surveillance, epidemiology, and end results (SEER) database, because CNT is known to improve survival in patients with metastatic renal cell carcinoma (mRCC). METHODS: Within the SEER database, we identified 6226 mRCC patients, who were either treated with CNT (n = 2038) or underwent no surgery (n = 4188) between 1989 and 2004. Chi-square and chi(2) trend tests, as well as multivariate logistic regression models, were used to assess the effect of age, gender, race, region of residence, and year of surgery on the rate of CNT. Adjustment was made for the size of the primary tumor. RESULTS: The overall rate of CNT was 30.5%. The rate of CNT increased in the most recent year quartile (P

AB - OBJECTIVE: To examine temporal, geographic, socioeconomic, and clinical determinants of cytoreductive nephrectomy (CNT) use in the surveillance, epidemiology, and end results (SEER) database, because CNT is known to improve survival in patients with metastatic renal cell carcinoma (mRCC). METHODS: Within the SEER database, we identified 6226 mRCC patients, who were either treated with CNT (n = 2038) or underwent no surgery (n = 4188) between 1989 and 2004. Chi-square and chi(2) trend tests, as well as multivariate logistic regression models, were used to assess the effect of age, gender, race, region of residence, and year of surgery on the rate of CNT. Adjustment was made for the size of the primary tumor. RESULTS: The overall rate of CNT was 30.5%. The rate of CNT increased in the most recent year quartile (P

M3 - SCORING: Zeitschriftenaufsatz

JO - UROLOGY

JF - UROLOGY

SN - 0090-4295

ER -